Tobias Max Philipp Hartwich
5PUBLICATIONS
39CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Aug 27, 2025
Preclinical Activity of Datopotamab Deruxtecan (Dato-DXd), an Antibody-Drug Conjugate Targeting TROP2, in Poorly Differentiated Endometrial Carcinomas.Niccolò G Santin, Namrata Sethi, Stefania Bellone
|Apr 29, 2025
Preclinical Activity of Datopotamab Deruxtecan, an Antibody-Drug Conjugate Targeting Trophoblast Cell-Surface Antigen 2, in Uterine Serous Carcinoma.Michelle Greenman, Cem Demirkiran, Stefania Bellone
|Jan 25, 2025
SORL1-Mediated EGFR and FGFR4 Regulation Enhances Chemoresistance in Ovarian Cancer.Ziyan Jiang, Fangfang Bi, Zhiping Ge
|Sep 07, 2023
In Vivo and In Vitro Efficacy of Trastuzumab Deruxtecan in Uterine Serous Carcinoma.Levent Mutlu, Diego D Manavella, Stefania Bellone
|Oct 27, 2022
Distinct Mechanisms of Mismatch-Repair Deficiency Delineate Two Modes of Response to Anti-PD-1 Immunotherapy in Endometrial Carcinoma.Ryan D Chow, Tai Michaels, Stefania Bellone
Pageof 1
Frequent Collaborators
4 joint publications
Stefania Bellone
4 joint publications
Alessandro D Santin
3 joint publications
Cem Demirkiran
3 joint publications
Blair McNamara
3 joint publications
Yang Yang-Hartwich
2 joint publications
Niccolo G Santin
2 joint publications
Namrata Sethi
2 joint publications
Victoria M Ettorre
2 joint publications
Michelle Greenman
2 joint publications
Natalia Buza
